Clara I. Extremina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Clara I. Extremina has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
A. Freitas da Fonseca
Instituto Piaget, Escola Superior de Saúde, Alameda Jean Piaget, Gulpilhares, 4405-678 Vila Nova de Gaia, Portugal
1 shared publicationA.I. Aguiar
REQUIMTE, Laboratório de Microbiologia, Faculdade de Farmácia, Universidade do Porto, Rua Anibal Cunha no 164, 4050-047 Porto, Portugal
1 shared publicationA.P. Fonseca
REQUIMTE, Laboratório de Microbiologia, Faculdade de Farmácia, Universidade do Porto, Rua Anibal Cunha no 164, 4050-047 Porto, Portugal
1 shared publicationAntónio P. Fonseca
REQUIMTE, Faculdade de Farmácia, Universidade do Porto, Rua Aníbal Cunha 164, 4050-047 Porto, Portugal
1 shared publicationL. Costa
REQUIMTE, Laboratório de Microbiologia, Faculdade de Farmácia, Universidade do Porto, Rua Anibal Cunha no 164, 4050-047 Porto, Portugal
1 shared publication- Luísa Peixe
UCIBIO, Unidade de Ciências Biomoleculares Aplicadas, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal
1 shared publication
Latest Publications
- 14 November 2010
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 84 (2) , 167-173
Optimization of processing conditions for the quantification of enterococci biofilms using microtitre-plates
- 14 November 2010
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 84 (2) , 167-173
Optimization of processing conditions for the quantification of enterococci biofilms using microtitre-plates
- 25 November 2009
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 35 (2) , 164-168
Anti-adhesion and antiproliferative cellulose triacetate membrane for prevention of biomaterial-centred infections associated with Staphylococcus epidermidis
- 25 November 2009
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 35 (2) , 164-168
Anti-adhesion and antiproliferative cellulose triacetate membrane for prevention of biomaterial-centred infections associated with Staphylococcus epidermidis